Funding for this research was provided by:
Experimental Therapeutics Center
National Institutes of Health (P30 CA008748)
Congressionally Directed Medical Research Programs (LC160212)
Mesothelioma Applied Research Foundation
Baker Street Foundation
Derfner Foundation
Joanne and John DallePezze Foundation
Article History
Received: 11 April 2017
Revised: 5 June 2017
Accepted: 7 June 2017
First Online: 28 July 2017
Compliance with ethical standards
:
: The authors declare that they have no conflicts of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: This is review article and not a study. Hence, there is no study participation involved and no requirement of consent.
: The author’s research is supported by grants from the National Institutes of Health (P30 CA008748), the U.S. Department of Defense (LC160212), the Mesothelioma Applied Research Foundation, the Baker Street Foundation, the Joanne and John DallePezze Foundation, the Derfner Foundation, and the Mr. William H. Goodwin and Alice Goodwin, the Commonwealth Foundation for Cancer Research, and the Experimental Therapeutics Center.
Free to read: This content has been made available to all.